J&J E-mails Link Research Center, Risperdal
E-mail messages released as part of a lawsuit over Johnson & Johnson's anti-psychotic Risperdal have revealed that the drugmaker worked with a renowned psychiatrist to launch a research center, allegedly for...To view the full article, register now.
Already a subscriber? Click here to view full article